First-trimester screening for trisomy-21 using a simplified method to assess the presence or absence of the fetal nasal bone

This publication has 17 references indexed in Scilit:

• Likelihood ratio for trisomy 21 in fetuses with absent nasal bone at the 11–14‐week scan
  Ultrasound in Obstetrics & Gynecology, 2004
• Nasal bone and trisomy 21: prenatal ultrasound and postmortem morphohistological study
  Ultrasound in Obstetrics & Gynecology, 2004
• Ultrasound evaluation of fetal nasal bone at 11 to 14 weeks in a consecutive series of 1906 fetuses
  Prenatal Diagnosis, 2003
• Measurement of nasal bone length at 11–14 weeks of pregnancy and its potential role in Down syndrome risk assessment
  Ultrasound in Obstetrics & Gynecology, 2003
• Absence of fetal nasal bone and aneuploidies at first‐trimester nuchal translucency screening in unselected pregnancies
  Prenatal Diagnosis, 2003
• Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free β‐hCG and PAPP‐A at 11 to 14 weeks
  Prenatal Diagnosis, 2003
• Association between first trimester absence of fetal nasal bone on ultrasound and Down syndrome
  Prenatal Diagnosis, 2002
• One‐stop clinic for assessment of risk for trisomy 21 at 11–14 weeks: a prospective study of 15 030 pregnancies
  Ultrasound in Obstetrics & Gynecology, 2002
• Absence of nasal bone in fetuses with trisomy 21 at 11–14 weeks of gestation: an observational study
  The Lancet, 2001
• First-Trimester down syndrome screening using dried blood biochemistry and nuchal translucency
  Obstetrics & Gynecology, 2000